Editors at the prestigious Annals of Internal Medicine recently told Live Action News that they allow authors of abortion studies to keep funding...
UPDATE, 9/11/19: Hours after four U.S. Senators sent a letter to Facebook CEO Mark Zuckerberg condemning the platform’s labeling of Live Action...
Abortion pill investors are doing their level best to remove the FDA’s safeguards on the abortion pill. This would make abortion less...
A report claiming abortion is safe, published in March of 2018 by the National Academies of Science (NASEM), was funded by abortion collaborators...
Three pro-abortion foundations and one anonymous donor are funding research and subsequent studies using flawed data from the so-called Turnaway study. The...
Five states in 2019 have passed pro-life measures requiring abortionists to inform women using the abortion pill about the possibility of abortion...
A new abortion pill study glorifying self-managed abortions is being funded by the pro-abortion TARA Health Foundation, the same organization behind funding dangerous abortion...
A TelAbortion study which promotes self-managed abortion via telemedicine has been accepted by the Journal Contraception, a publication staffed by abortion insiders which previously...
Just as abortion supporters rage over new pro-life laws in Georgia and Alabama, claiming that women could be investigated for miscarriages, comes...
The abortion lobby claims that late-term (or “later”) abortions are “rare” and that they are needed because of the health of the mother...
UPDATE, 10/3/2019: Live Action News has discovered that sometime between August and September 2019, the status of this clinical trial was changed...
The FDA has approved a generic version of the abortion pill Mifeprex, at a time when more deaths are being reported and...
(Pregnancy Help News) Definitively derided as “unscientific” by abortion fanatics the world over, Abortion Pill Reversal is now being put to the test...
UPDATE, 10/3/2019: Live Action News has discovered that sometime between August and September 2019, the status of this clinical trial was changed...